Elicio Therapeutics (ELTX) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Elicio Therapeutics (ELTX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||
Total Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 650K (-60.61%) | 1.65M (-93.44%) | 25M (+1621.92%) | 1.46M (+170.37%) | 540K (+45.95%) | 370K (+94.74%) | 190K | - | - | - |
Cost Of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 430K | - | - | - | 130K (-62.86%) | 350K (+6.06%) | 330K (-13.16%) | 380K |
Costof Goods And Services Sold | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 430K | - | - | - | 130K (-62.86%) | 350K (+6.06%) | 330K (-13.16%) | 380K |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.30M | - | - | - | 25M (+1591.78%) | 1.46M (+170.37%) | 540K (+45.95%) | 370K (+428.57%) | 70K | -350.00K (+6.06%) | -330.00K (-13.16%) | -380.00K |
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 6.76M (+33.07%) | 5.08M (+0.79%) | 5.04M (-28.10%) | 7.01M (-9.90%) | 7.78M (-27.36%) | 11M (+48.54%) | 7.21M (-11.86%) | 8.18M (+8.20%) | 7.56M (+22.73%) | 6.16M (-15.15%) | 7.26M (+46.96%) | 4.94M (-9.85%) | 5.48M | -3.20M | 4.59M (-8.93%) | 5.04M (-56.81%) | 12M (+74.96%) | 6.67M (-49.81%) | 13M (-7.96%) | 14M (+0.98%) | 14M (+29.18%) | 11M (+81.77%) | 6.09M (-50.20%) | 12M (+27.40%) | 9.60M |
Selling General And Administrative | 3.85M (+2.39%) | 3.76M (+24.92%) | 3.01M (-2.59%) | 3.09M (+4.39%) | 2.96M (+6.86%) | 2.77M (-11.78%) | 3.14M (+14.60%) | 2.74M (+2.24%) | 2.68M (-17.28%) | 3.24M (-7.69%) | 3.51M (+24.03%) | 2.83M (+21.98%) | 2.32M | -1.20M | 1.18M (-0.84%) | 1.19M (-73.38%) | 4.47M (+6.18%) | 4.21M (+7.12%) | 3.93M (-9.45%) | 4.34M (-27.79%) | 6.01M (+92.63%) | 3.12M (-47.83%) | 5.98M (+9.93%) | 5.44M (+57.23%) | 3.46M |
Operating Expenses | 11M (+19.91%) | 8.84M (+9.81%) | 8.05M (-20.22%) | 10M (-6.05%) | 11M (-20.33%) | 13M (+30.37%) | 10M (-5.31%) | 11M (+6.64%) | 10M (+9.05%) | 9.39M (-12.81%) | 11M (+38.43%) | 7.78M (-0.38%) | 7.81M | -4.40M | 5.77M (-7.38%) | 6.23M (-61.38%) | 16M (+42.62%) | 11M (-34.32%) | 17M (-8.31%) | 19M (-7.53%) | 20M (+41.93%) | 14M (+15.31%) | 12M (-31.06%) | 18M (+34.03%) | 13M |
Depreciation And Amortization | 50K | -50.00K | 100K (0.00%) | 100K (+100.00%) | 50K (-64.29%) | 140K | - | 100K (+25.00%) | 80K (-70.37%) | 270K | - | - | 110K (-57.69%) | 260K (+160.00%) | 100K | - | 30K (-25.00%) | 40K (+100.00%) | 20K (0.00%) | 20K (+100.00%) | 10K | -20.00K | 50K (0.00%) | 50K (+66.67%) | 30K |
Operating Income | |||||||||||||||||||||||||
Operating Income | -10.60M (+19.91%) | -8.84M (+9.95%) | -8.04M (-20.32%) | -10.09M (-6.05%) | -10.74M (-20.33%) | -13.48M (+30.37%) | -10.34M (-5.31%) | -10.92M (+6.64%) | -10.24M (+9.05%) | -9.39M (-12.81%) | -10.77M (+38.43%) | -7.78M (-0.26%) | -7.80M | 2.75M | -5.77M (-7.38%) | -6.23M (-56.98%) | -14.48M | 15M | -15.76M (-13.60%) | -18.24M (-8.53%) | -19.94M (+43.97%) | -13.85M (+19.60%) | -11.58M (-32.95%) | -17.27M (+37.39%) | -12.57M |
Ebit | -10.60M (+19.91%) | -8.84M (+9.95%) | -8.04M (-20.32%) | -10.09M (-6.05%) | -10.74M (-20.33%) | -13.48M (+30.37%) | -10.34M (-5.31%) | -10.92M (+6.64%) | -10.24M (+9.05%) | -9.39M (-12.81%) | -10.77M (+38.43%) | -7.78M (-0.26%) | -7.80M | 2.75M | -5.77M (-7.38%) | -6.23M (-56.98%) | -14.48M | 15M | -15.76M (-13.60%) | -18.24M (-8.53%) | -19.94M (+43.97%) | -13.85M (+19.60%) | -11.58M (-32.95%) | -17.27M (+37.39%) | -12.57M |
EBITDA | -10.56M (+18.79%) | -8.89M (+11.96%) | -7.94M (-20.52%) | -9.99M (-6.46%) | -10.68M (-19.94%) | -13.34M (+29.01%) | -10.34M (-4.44%) | -10.82M (+6.50%) | -10.16M (+1.09%) | -10.05M (-6.69%) | -10.77M (+57.46%) | -6.84M (-11.05%) | -7.69M | 3.01M | -5.67M (-8.99%) | -6.23M (-56.89%) | -14.45M | 15M | -15.73M (-13.67%) | -18.22M (-8.58%) | -19.93M (+43.69%) | -13.87M (+20.19%) | -11.54M (-32.98%) | -17.22M (+37.32%) | -12.54M |
Other Income / Expenses | |||||||||||||||||||||||||
Interest Income | 160K | -580.00K | 200K (+17.65%) | 170K (-19.05%) | 210K | -320.00K | 190K (+35.71%) | 140K | - | -280.00K | 250K (+525.00%) | 40K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense | 410K (+20.59%) | 340K (-20.93%) | 430K (+126.32%) | 190K (+5.56%) | 180K (-21.74%) | 230K (+64.29%) | 140K (+180.00%) | 50K (+25.00%) | 40K | - | - | 710K (+108.82%) | 340K (-76.55%) | 1.45M (+34.26%) | 1.08M (+0.93%) | 1.07M | - | - | - | - | - | - | - | - | - |
Net Interest Income | 160K | -580.00K | 200K (+17.65%) | 170K (-19.05%) | 210K | -290.00K | 190K (+35.71%) | 140K | -40.00K (-86.21%) | -290.00K | 250K | -670.00K (+97.06%) | -340.00K (-76.55%) | -1.45M (+34.26%) | -1.08M (+0.93%) | -1.07M | - | - | - | - | - | - | - | - | - |
Other Non Operating Income | -1.22M (-34.41%) | -1.86M (-8.82%) | -2.04M (+334.04%) | -470.00K (0.00%) | -470.00K (-93.20%) | -6.91M (-18.61%) | -8.49M | 3.70M | -1.59M | 550K (+400.00%) | 110K (-50.00%) | 220K | -220.00K (-95.08%) | -4.47M (+212.59%) | -1.43M (+33.64%) | -1.07M | 250K | -15.27M | 50K (-95.73%) | 1.17M | -16.75M (-32.54%) | -24.83M (+308.39%) | -6.08M (+98.05%) | -3.07M (+372.31%) | -650.00K |
Net Income | |||||||||||||||||||||||||
Income Before Tax | - | -39.57M | - | - | - | -51.90M | - | - | - | - | - | - | - | -38.80M | - | - | - | -54.57M | - | - | - | -80.11M | - | - | - |
Income Tax Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -800.00K | 800K | - | - |
Net Income From Continuing Operations | -11.82M (+53.11%) | -7.72M (-23.41%) | -10.08M (-4.55%) | -10.56M (-5.80%) | -11.21M (-19.93%) | -14.00M (-25.69%) | -18.84M (+160.58%) | -7.23M (-38.88%) | -11.83M (+32.18%) | -8.95M (-16.04%) | -10.66M (+41.01%) | -7.56M (-5.85%) | -8.03M (+20.75%) | -6.65M (-7.64%) | -7.20M (-1.37%) | -7.30M (+3.40%) | -7.06M | 15M | -15.70M (-8.03%) | -17.07M (-53.48%) | -36.69M (+27.09%) | -28.87M (+63.38%) | -17.67M (-13.13%) | -20.34M (+53.86%) | -13.22M |
Net Income | -11.82M (+53.11%) | -7.72M (-23.41%) | -10.08M (-4.55%) | -10.56M (-5.80%) | -11.21M (-19.93%) | -14.00M (-25.69%) | -18.84M (+160.58%) | -7.23M (-38.88%) | -11.83M (+32.18%) | -8.95M (-16.04%) | -10.66M (+41.01%) | -7.56M (-5.85%) | -8.03M (+20.75%) | -6.65M (-7.64%) | -7.20M (-1.37%) | -7.30M (+3.40%) | -7.06M | 15M | -15.70M (-8.03%) | -17.07M (-53.48%) | -36.69M (+27.09%) | -28.87M (+63.38%) | -17.67M (-13.13%) | -20.34M (+53.86%) | -13.22M |
Comprehensive Income Net Of Tax | -11.82M (-70.09%) | -39.52M (+293.63%) | -10.04M (-4.29%) | -10.49M (-6.17%) | -11.18M (-78.45%) | -51.88M (+175.96%) | -18.80M (+161.11%) | -7.20M (-39.50%) | -11.90M (-66.37%) | -35.39M (+231.37%) | -10.68M (+41.27%) | -7.56M (-5.85%) | -8.03M (-71.53%) | -28.21M (+291.81%) | -7.20M (-1.37%) | -7.30M (-49.09%) | -14.34M (-73.61%) | -54.34M (+249.23%) | -15.56M (-8.47%) | -17.00M (-53.60%) | -36.64M (-54.45%) | -80.44M (+354.72%) | -17.69M (-13.88%) | -20.54M (+57.15%) | -13.07M |